The stocks of FOXA have been given a rating of “hold” by around nineteen different research firms that have been covering the company. In a report, two of the research analysts have given the company a rating of sell, while six others have given the company a rating of hold. Close to six others analysts have provided the company with a rating of buy. The price target of the company over a period of one year has been set at $34.
The Stock Commentary Of FOXA
There have been quite a few research equities that have commented on the stocks of FOXA. Barclays has already increased the price target of the company from $29 to $38 in a 29th March research report. Morgan Stanley has also increased the price target of the company from $36 to $45 with a rating of overweight in a 27th April research report. Zacks Investment Research has also reduced the price rating of the company from buy to hold with a price target of $33 in an 11th February research report. Macquarie has also increased the price target to $33 with a rating of neutral in a 28th January research report.
The stocks of FOXA traded on Monday at $37.42. The moving average price of the company over a period of 50 days was $39, with the moving average price of the company over 200 days set at $32.35. The current ratio of the company is 4.21, with a 3.57 quick ratio, and a 0.74 debt-to-equity ratio. The market cap of the company is $22.10 billion, with a 14.17 PE ratio, and a 7.35 PEG ratio. The year low of the company is $23.57, with the year high of $44.80.
FOXA had already updated its quarterly report on the 8th of February. The EPS reported by the company during this period was $0.16, which was more than the consensus estimate of $0.03.